CeriBell Inc. Common Stock (CBLL)
Stock · NASDAQ · Health Care
$25.04as of 10/16/2026
Price chart
Active signals
CBLL Signal Track Record
How signals performed across all stocks →What CBLL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 10 | -1.1% | 40% | September 17, 2026 |
| Bollinger Band Breakout | 7 | -9.8% | 43% | August 11, 2026 |
| Bollinger Band Breakdown | 6 | +4.4% | 50% | July 21, 2026 |
| 200-Day Moving Average TouchActive now | 4 | +23.3% | 100% | August 4, 2026 |
| Any 20-session window (baseline) | +1.6% | 58% |
Computed by MarketWall from daily closing prices since July 31, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CBLL
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals;…
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Employees
- 327
- Website
- ceribell.com/
Fundamentals
- 1-day range
- $25.02$26.72
- Market cap
- $692.45M
- P/E (trailing)
- —
- P/E (forward)
- -16.35
- EPS (trailing)
- $-1.76
- Dividend yield
- —
- Beta
- 0.83
- Avg. volume
- 381.4K
How CeriBell Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub
Forecasts
7 analyst ratings
CeriBell Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CBLLCeriBell Inc. Common Stock$25.04▼ 9.41%Market cap $692.45MP/E —$10.85$26.63
- INMDInMode Ltd. Ordinary Shares$14.16▼ 1.12%Market cap $957.98MP/E 10.66$12.72$16.67
- CVCapsoVision Inc. Common Stock$6.53▲ 1.24%Market cap $344.75MP/E —$4.46$15.37
- FOCLEDAP TMS S.A. American Depositary Shares$4.09▼ 0.97%Market cap $228.65MP/E —$3.99$6.4
- STXSStereotaxis Inc. Common Stock$1.01▼ 3.81%Market cap $133.19MP/E —$1.02$3.2
- VANIVivani Medical Inc. Common Stock (DE)$1.12▼ 2.61%Market cap $117.28MP/E —$0.9227$1.92
- HSDTSolana Company Class A Common Stock (DE)$2.24▼ 4.68%Market cap $98.09MP/E —$1.19$16.81
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CBLL CeriBell Inc. Common Stock | $692.45M | — | $25.04 | ▼ 9.41% | $10.85$26.63 |
| INMD InMode Ltd. Ordinary Shares | $957.98M | 10.66 | $14.16 | ▼ 1.12% | $12.72$16.67 |
| CV CapsoVision Inc. Common Stock | $344.75M | — | $6.53 | ▲ 1.24% | $4.46$15.37 |
| FOCL EDAP TMS S.A. American Depositary Shares | $228.65M | — | $4.09 | ▼ 0.97% | $3.99$6.4 |
| STXS Stereotaxis Inc. Common Stock | $133.19M | — | $1.01 | ▼ 3.81% | $1.02$3.2 |
| VANI Vivani Medical Inc. Common Stock (DE) | $117.28M | — | $1.12 | ▼ 2.61% | $0.9227$1.92 |
| HSDT Solana Company Class A Common Stock (DE) | $98.09M | — | $2.24 | ▼ 4.68% | $1.19$16.81 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- David Foehr · August 24, 2026 · Sale859 @ $23.95
- Joseph S. Manni · August 21, 2026 · Sale1.4K @ $24.02
- David Foehr · August 21, 2026 · Sale993 @ $24.02
- Raymond Woo · August 21, 2026 · Sale2.0K @ $24.02
- Scott Blumberg · August 21, 2026 · Sale1.5K @ $24.02
- Xingjuan Chao · August 21, 2026 · Sale6.1K @ $24.02
- Joseph Michael Taylor · August 13, 2026 · Sale13.1K @ $23.4
- Xingjuan Chao · August 3, 2026 · Option Exercise23.6K @ $4.7
- Xingjuan Chao · August 3, 2026 · Option Exercise1.4K @ $4.7
- Xingjuan Chao · August 3, 2026 · Sale39.0K @ $18.32
- Thomas A. West · July 28, 2026 · Grant16.0K
- Sharon O'Keefe · July 28, 2026 · Grant16.0K
- Xingjuan Chao · July 7, 2026 · Option Exercise23.6K @ $4.7
- Xingjuan Chao · July 7, 2026 · Option Exercise1.4K @ $4.7
- Xingjuan Chao · July 7, 2026 · Sale23.6K @ $19.9
Institutional Ownership
March 31, 2026
- Total shares held
- 29.21M
- Total value held
- $529.97M
- Institutional holders
- 118
- Unknown4.85M
- Unknown3.97M
- Unknown2.21M
- Unknown1.81M
- Unknown1.40M
- Unknown1.16M
- Unknown1.14M
- Unknown939.5K
- Unknown809.5K
- Unknown756.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
CeriBell Gets FDA Clearance for New EEG Analysis Tools
CeriBell Inc. announced that the FDA has granted 510(k) clearance for its quantitative EEG trending and amplitude-integrated EEG analysis features. This regulatory approval allows the company to market these specific diagnostic tools, which may support its clinical utility and product roadmap. The stock is currently trading within its 52-week range, with analyst targets averaging $28.00.
CeriBell Gets FDA Clearance for New EEG Analysis Tools. CeriBell Inc. announced that the FDA has granted 510(k) clearance for its quantitative EEG trending and amplitude-integrated EEG analysis features. This regulatory approval allows the company to market these specific diagnostic tools, which may support its clinical utility and product roadmap. The stock is currently trading within its 52-week range, with analyst targets averaging $28.00.